ANDA 211044, held by Teva Pharms USA Inc. Riociguat.
As of Nov 16, 2026, ANDA 211044 (Riociguat), held by Teva Pharms USA Inc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 30, 2022 | Original application | Tentative approval | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters